Phibro Animal Health Corporation (PAHC)
NASDAQ: PAHC · Real-Time Price · USD
34.56
+0.11 (0.32%)
At close: Sep 18, 2026, 4:00 PM EDT
34.56
0.00 (0.01%)
After-hours: Sep 18, 2026, 7:30 PM EDT

Phibro Animal Health Income Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
1,5181,2961,018977.89942.26
Revenue Growth
17.12%27.37%4.07%3.78%13.07%
Cost of Revenue
1,012886.79704.07679.65656.55
Gross Profit
505.97409.42313.61298.24285.72
Selling, General & Admin
309.33268.15250.92223.35183.53
Research & Development
----20.83
Amortization of Goodwill & Intangibles
2.42.382.993.052.98
Operating Expenses
311.73270.53253.91226.39207.34
Operating Income
194.24138.8959.7171.8578.38
Interest Expense
-46.42-35.26-23.01-18.68-12.69
Interest & Investment Income
1.992.624.473.360.82
Currency Exchange Gain (Loss)
-12.62-7.87-23.86-2.465.22
EBT Excluding Unusual Items
137.1998.3817.3154.0771.72
Merger & Restructuring Charges
-11.91-25.98-7.29--0.6
Gain (Loss) on Sale of Investments
----1.2
Asset Writedown
--5.33---
Other Unusual Items
8.5-1.96---
Pretax Income
137.3567.9910.9254.0772.33
Income Tax Expense
37.6319.738.521.4723.15
Net Income
99.7248.262.4232.6149.18
Net Income to Common
99.7248.262.4232.6149.18
Net Income Growth
106.61%1897.68%-92.59%-33.69%-9.58%
Shares Outstanding (Basic)
4141414141
Shares Outstanding (Diluted)
4141414141
Shares Change
0.70%0.38%0.05%--
EPS (Basic)
2.461.190.060.811.21
EPS (Diluted)
2.431.190.060.811.21
EPS Growth
104.20%1895.04%-92.59%-33.47%-9.70%

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Free Cash Flow
9.8741.8346.36-38.48-5.4
Free Cash Flow Per Share
0.241.031.14-0.95-0.13
Dividend Per Share
0.4800.4800.4800.4800.480
Dividend Growth
0%0%0%0%0%
Gross Margin
33.33%31.59%30.82%30.50%30.32%
Operating Margin
12.80%10.71%5.87%7.35%8.32%
Profit Margin
6.57%3.72%0.24%3.33%5.22%
Free Cash Flow Margin
0.65%3.23%4.55%-3.94%-0.57%
EBITDA
244.23183.0894.45104.4110.04
EBITDA Margin
16.09%14.12%9.28%10.68%11.68%
D&A For EBITDA
49.9944.1834.7432.5631.66
EBIT
194.24138.8959.7171.8578.38
EBIT Margin
12.80%10.71%5.87%7.35%8.32%
Effective Tax Rate
27.40%29.02%77.87%39.70%32.01%
SEC Filings: 10-K · 10-Q